Home > Keywords >
| Catalog | name | Description | price |
|---|---|---|---|
| R-R-2772 | ZJ43 CAS No.723331-20-2 | ZJ43/CAS No.723331-20-2 is a potent NAAG peptidase inhibitor, with an IC50 of 2.4 nM and a Ki of 0.8 nM. ZJ43 sufficiently activates group II mGluR and reduces some of the behavioral effects of PCP. ZJ43 shows an analgesic effect in neuropathic and inflammatory and pain models. | price> |
| R-C-1073 | (R)-FL-118 CAS:151636-76-9 | (R)-FL-118 is a derivative of Camptothecin(C175150),which is antitumor alkaloid that binds to the DNA-topoisomerase I complex,inhibiting the reassociation of DNA after cleavage by topoisomerase I,trapping the enzyme in a covalent linkage with DNA. | price> |
| R-R-2773 | FEMA 4774 CAS No.1359963-68-0 | FEMA 4774/CAS No.1359963-68-0 is a positive allosteric modulator of taste receptors T1R2 and T1R3, two subunits of the human sweet taste receptor. FEMA 4774 is also used as a sucrose sweetness enhancer. | price> |
| R-C-1074 | TBA-354 CAS:1257426-19-9 | TBA-354 is a potent anti-tuberculosis compound;maintains activity against Mycobacterium tuberculosis H37Rv isogenic monoresistant strains and clinical drug-sensitive and drug-resistant isolates. | price> |
| R-R-2774 | Pramlintide acetate CAS No.187887-46-3 | Pramlintide acetate/CAS No.187887-46-3 is a polypeptide analogue of human amylin. Pramlintide acetate, an antidiabetic agent, is antineoplastic in colorectal cancer. | price> |
| R-C-1075 | BMH-21 CAS:896705-16-1 | BMH-21 is a potent small molecule DNA intercalator.BMH-21 binds ribosomal DNA and inhibits RNA polymerase I(Pol I)transcription. | price> |
| R-R-2775 | a-CGRP (mouse, rat) (TFA) | α-CGRP (mouse, rat) TFA, a neuropeptide (calcitonin gene-related peptide (CGRP)) mainly expressed in neuromuscular junction, is a potent vasodilator. α-CGRP (mouse, rat) TFA can lead to a fall in blood pressure and an increase in heart rate by peripheral administration, also relax colonie smooth muscle. α-CGRP (mouse, rat) TFA has the potential in cardiovascular, pro-inflammatory, migraine and metabolic studies. | price> |
| R-C-1076 | Poziotinib (HM781-36B) CAS:1092364-38-9 | Poziotinib(HM781-36B)is an orally active,irreversible pan-HER inhibitor,which effectively inhibits EGFRwt,HER-2 and HER-4 with IC50s of 3.2, 5.3 and 23.5 nM, respectively.Poziotinib(HM781-36B)also shows excellent inhibitory activities against mutated EGFRs,including EGFRT790M and EGFRL858R/T790M,with IC50s of 4.2 and 2.2 nM,respectively.Excellent antitumor activity. | price> |
| R-R-2776 | Cagrilintide acetate | Cagrilintide acetate is a non-selective AMYR/CTR agonist and long-acting acylated amylase analogue. Cagrilintide acetate causes a reduction in food intake and significant weight loss in a dose-dependent manner. Cagrilintide acetate can be used in obesity studies. | price> |
| R-C-1077 | PF-431396 CAS:717906-29-1 | PF-431396 hydrate has been used as a dual inhibitor of proline-rich tyrosine kinase 2(PYK2)/focal adhesion kinase(FAK)inhibitor to study its effects on phosphorylation of Yes-associated protein(YAP)at Ser127 and steady state of transcriptional coactivator with PDZ-binding motif(TAZ).It has also been used as a PYK2/FAK inhibitor to study its effects on protein kinase A activation in human sperm samples. | price> |
| R-R-2777 | b-CGRP, human TFA | β-CGRP, human TFA (Human β-CGRP TFA) is one of calcitonin peptides, acts via the complex of calcitonin-receptor-like receptor (CRLR) and receptor-activity-modifying protein (RAMP), with IC50s of 1 nM and 300 nM for CRLR/RAMP1 and CRLR/RAMP2 in cells. | price> |
| R-C-1078 | GSK2578125A CAS:1285515-21-0 | GSK2578215A is a potent and highly selective LRRK2 inhibitor,which exhibits IC50s of around 10 nM against both wild-type LRRK2 and the G2019S mutant. | price> |
| R-R-2778 | Olcegepant hydrochloride CAS No.586368-06-1 | Olcegepant hydrochloride (BIBN-4096 hydrochloride)/CAS No.586368-06-1 is a potent and selective non-peptide antagonist of the calcitonin gene-related peptide receptor 1 (CGRP1) with IC50 of 0.03 nM and with a Ki of 14.4 pM for human CGRP. | price> |
| R-C-1079 | Berzosertib (VE-822) CAS:1232416-25-9 | VE-822 is an inhibitor of ataxia-telangiectasia mutated(ATM)Rad3-related protein kinase(ATR),a regulator of DNA damage repair, with Ki and IC50 values of <0.2 and 19 nM,respectively,in pancreatic cancer cells in vitro.1 It is selective for ATR over ATM (Ki=34 nM;IC50=2,600 nM) as well as DNA-PK,mTOR,and PI3Kγ(Kis= >4,000,>1,000,and 220 nM,respectively).In cultured COLO 205 colorectal cancer cells,VE-822(80 nM)reduces the IC50 of the topoisomerase 1 inhibitor SN-38 by at least 8-fold.2 In a mouse xenograft model,it delays the growth of radiation-treated PSN-1 pancreatic cancer xenografts by 2-3-fold relative to radiation alone when administered at a dose of 60 mg/kg.VE-822 also enhances the tumoricidal effects of cisplatin against primary human lung cancer xenografts and the effects of the topoisomerase inhibitor irinotecan against COLO 205 colorectal tumors in mice. | price> |
| R-R-2779 | Telcagepant CAS No.781649-09-0 | Telcagepant (MK-0974)/CAS No.781649-09-0 is an orally active calcitonin gene-related peptide (CGRP) receptor antagonist with Kis of 0.77 nM and 1.2 nM for human and rhesus CGRP receptors, respectively. | price> |
| R-C-1080 | VE821 CAS:1232410-49-9 | VE-821 is a potent ATP-competitive inhibitor of ATR with Ki/IC50 of 13 nM/26 nM. | price> |
| R-R-2780 | BCTC CAS No.393514-24-4 | BCTC/CAS No.393514-24-4 is an orally active current inhibitor of vanilloid receptor type 1 (VR1). BCTC is a transient receptor potential cation channel subfamily M member 8 (TRPM8) and transient receptor potential vanilloid 1 (TRPV1) antagonist. BCTC is an insulin sensitizer and secretor. BCTC has anticancer and analgesic effects. | price> |
| R-C-1081 | PI3065 CAS:955977-50-1 | PI 3065 is a p110δ-selective PI3K inhibitor with Ki and IC50 values of 1.5 nM and 5 nM,respectively.Administration of PI 3065 suppressed 4T1 tumour growth and metastasis,to a similar extent as genetic inactivation of p110δ,marked by initial tumour progression,followed by tumour regression. | price> |
| R-R-2781 | MK-3207 CAS No.957118-49-9 | MK-3207/CAS No.957118-49-9 is an orally active, highly selective and species-specific CGRP receptor antagonist (for human CGRP receptor: IC50=0.12 nM; Ki=0.024 nM). MK-3207 can be used for migraine studies. | price> |
| R-C-1082 | Ro 48-8071 fumarate CAS:89197-69-1 | Ro 48-8071 blocked human liver OSC and cholesterol synthesis in HepG2 cells in the nanomolar range;in cells it triggered the production of monooxidosqualene, dioxidosqualene,and epoxycholesterol.Administration of Ro 48-8071 to mice with BT-474 tumor xenografts prevented tumor growth,with no apparent toxicity.Ro 48-8071 degraded ERα while concomitantly inducing the anti-proliferative protein ERβ. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


